CellCo
1 known investors
CellCo applies computational simulation, generative AI, and medicinal chemistry to design glycan-enabled therapeutics, engineering glycan ligands that direct RNA, small molecules, and antibodies to specific tissues and cell types. It develops platforms for molecular dynamics, synthetic data generation, and foundation models targeting glycan chemistry, immune modulation, and targeted drug delivery.
Investors · 1
Frequently asked questions
- What does CellCo do?
- CellCo applies computational simulation, generative AI, and medicinal chemistry to design glycan-enabled therapeutics, engineering glycan ligands that direct RNA, small molecules, and antibodies to specific tissues and cell types. It develops platforms for molecular dynamics, synthetic data generation, and foundation models targeting glycan chemistry, immune modulation, and targeted drug delivery.
- Who are CellCo's investors?
- CellCo's investors include Draper Associates.